AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28728869 — intervention group
Group type: EXPERIMENTAL
Intervention: Running subcuticular sutures (RSS)
Number of subjects: 142
Study 28728869 — intervention group
Group type: COMPARATOR
Intervention: Simple interrupted sutures (SIS)
Number of subjects: 142
Study 27026365 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose hemodialysis (Kt/Vurea of 1.71)
Number of subjects: 1281
Study 27026365 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose hemodialysis
Number of subjects: 1281
Study 27026365 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Kt/Vurea of 1.32)
Number of subjects: 1281
Study 24759796 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (20/3.75 mg)
Number of subjects: 1363
Study 24759796 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (300/75 mg)
Number of subjects: 1363
Study 21986689 — intervention group
Group type: EXPERIMENTAL
Intervention: AT before ST
Number of subjects: 8
Study 21986689 — intervention group
Group type: EXPERIMENTAL
Intervention: AT between 2 blocks of ST
Number of subjects: 8
Study 21986689 — intervention group
Group type: COMPARATOR
Intervention: AT after ST
Number of subjects: 8
Study 21986689 — intervention group
Group type: EXPERIMENTAL
Intervention: All sequences
Number of subjects: 8
Study 19531038 — intervention group
Group type: EXPERIMENTAL
Intervention: Quick change (QC) method
Number of subjects: 30
Study 19531038 — intervention group
Group type: COMPARATOR
Intervention: Double pumping (DP) method
Number of subjects: 30
Study 17688173 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin with water
Number of subjects: 11
Study 17688173 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin with Five Alive fruit juice
Number of subjects: 11
Study 15356662 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (average weight loss of 28 kg)
Number of subjects: 3756
Study 15356662 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment (weight stable)
Number of subjects: 3756
Study 15356662 — intervention group
Group type: COMPARATOR
Intervention: Reference group (normal-weight subjects)
Number of subjects: 3756
Study 11145766 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 204
Study 11145766 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 204
Study 11145766 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam plus Nitrous oxide
Number of subjects: 204
Study 11145766 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 204
Study 9840527 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA flow cytometry (DNA‐FCM) analysis
Number of subjects: 110
Study 8302340 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole (100 mg per day)
Number of subjects: 155
Study 8302340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 2735022 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinetic treatment table (KTT)
Number of subjects: 30
Study 2735022 — intervention group
Group type: COMPARATOR
Intervention: Conventional bed
Number of subjects: 30
Study 1093638 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin (two oral doses of 1 g. 5 hours apart)
Number of subjects: 1124
Study 1093638 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline (0.3 g. single oral dose)
Number of subjects: 1124
Study 1093638 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 1124
Study 1093638 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 1124
Study 30987813 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun exposure (daily ≥20–30 min around noon)
Number of subjects: 150
Study 30987813 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D3 (500 IU/d)
Number of subjects: 150
Study 30987813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 30646944 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1: Clinician-guided self-management program (iFightDepression®)
Number of subjects: 363
Study 30646944 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 2: Clinician-guided group chat intervention
Number of subjects: 363
Study 30646944 — intervention group
Group type: COMPARATOR
Intervention: Control intervention: Psycho-educational website on depressive symptoms
Number of subjects: 363
Study 30646944 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 363
Study 28099478 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive information delivery using an online trivia-style gamification platform
Number of subjects: 0
Study 28099478 — intervention group
Group type: COMPARATOR
Intervention: Passive information delivery via Amazon Mechanical Turk
Number of subjects: 0
Study 26054203 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus bloodletting
Number of subjects: 120
Study 26054203 — intervention group
Group type: COMPARATOR
Intervention: Simple acupuncture therapy
Number of subjects: 120
Study 23775222 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention
Number of subjects: 37
Study 21811202 — intervention group
Group type: EXPERIMENTAL
Intervention: Triage team present (physician, nurse, and nurse assistant)
Number of subjects: 1726
Study 21811202 — intervention group
Group type: EXPERIMENTAL
Intervention: Triage team present
Number of subjects: 1726
Study 21811202 — intervention group
Group type: COMPARATOR
Intervention: No triage team present
Number of subjects: 1726
Study 18695308 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin (low molecular-weight heparin)
Number of subjects: 99
Study 18695308 — intervention group
Group type: COMPARATOR
Intervention: No drug (control)
Number of subjects: 99
Study 16950471 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine challenge during intra-operative assessment
Number of subjects: 57
Study 16950471 — intervention group
Group type: COMPARATOR
Intervention: Intra-operative assessment without phenylephrine
Number of subjects: 57
Study 12867583 — intervention group
Group type: COMPARATOR
Intervention: Diffuse systemic sclerosis (dSSc) patients
Number of subjects: 234
Study 12867583 — intervention group
Group type: COMPARATOR
Intervention: Haplotype distribution in dSSc patients
Number of subjects: 234
Study 10863252 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical rotary manipulation on the ipsilateral side of the lateral flexion fixation(s) (Group A)
Number of subjects: 30
Study 10863252 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine lateral break manipulation on the contralateral side of the lateral flexion fixation(s) (Group B)
Number of subjects: 30
Study 10863252 — intervention group
Group type: COMPARATOR
Intervention: Both treatments (Group A and Group B)
Number of subjects: 30
Study 9202555 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic muscle exercise
Number of subjects: 49
Study 9202555 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethral milking
Number of subjects: 49
Study 9202555 — intervention group
Group type: COMPARATOR
Intervention: Counselling
Number of subjects: 49
Study 1440485 — intervention group
Group type: COMPARATOR
Intervention: Routine diagnostic approach
Number of subjects: 220
Study 1440485 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of a lung segment reference chart
Number of subjects: 220
Study 2429844 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone 300 mg single dose
Number of subjects: 11
Study 2429844 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone 150 mg t.i.d. multiple doses
Number of subjects: 11
Study 2429844 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone 150 mg and 300 mg single doses
Number of subjects: 11
Study 2429844 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone metabolites
Number of subjects: 11
Study 2429844 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic range of propafenone (0.5-2.0 micrograms/ml)
Number of subjects: 11
Study 31162082 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic peritoneal lavage
Number of subjects: 0
Study 31162082 — intervention group
Group type: COMPARATOR
Intervention: Sigmoidectomy
Number of subjects: 0
Study 30253403 — intervention group
Group type: EXPERIMENTAL
Intervention: CinnaPoietin® (epoetin beta, CinnaGen)
Number of subjects: 156
Study 30253403 — intervention group
Group type: COMPARATOR
Intervention: Eprex® (epoetin alfa, Janssen Cilag)
Number of subjects: 156
Study 27147591 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT plus modafinil (400 mg/day)
Number of subjects: 65
Study 27147591 — intervention group
Group type: COMPARATOR
Intervention: Only CBT
Number of subjects: 65
Study 25011693 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 300mg daily
Number of subjects: 82
Study 25011693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 22542724 — intervention group
Group type: EXPERIMENTAL
Intervention: Metreleptin (0.02 mg/kg/d for two months; 0.04 mg/kg/d for a further two months)
Number of subjects: 17
Study 22542724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 19898246 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV/3TC/LPV/r
Number of subjects: 0
Study 19898246 — intervention group
Group type: COMPARATOR
Intervention: NVP/LPV/r
Number of subjects: 0
Study 17629471 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained group (VT) using MDI
Number of subjects: 163
Study 17629471 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained group (VT) using SDSK
Number of subjects: 163
Study 17629471 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained group (VT) using STBH
Number of subjects: 163
Study 17629471 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained group (VT) using SHAND
Number of subjects: 163
Study 17629471 — intervention group
Group type: COMPARATOR
Intervention: Non-trained group (NT)
Number of subjects: 163
Study 15668620 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster counseling
Number of subjects: 1653
Study 15668620 — intervention group
Group type: COMPARATOR
Intervention: No booster counseling
Number of subjects: 1653
Study 14561567 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10928294 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin (CyA)
Number of subjects: 46
Study 10928294 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (Aza)
Number of subjects: 46
Study 8695711 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN with exclusive use catheter (Group I)
Number of subjects: 70
Study 8695711 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN with a catheter through which antibiotic medication is administered in 'Y' (Group II)
Number of subjects: 70
Study 8695711 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN with a catheter through which non-antibiotic medication is administered in 'Y' (Group III)
Number of subjects: 70
Study 8695711 — intervention group
Group type: COMPARATOR
Intervention: Comparison of infection and number of manipulations
Number of subjects: 70
Study 8695711 — intervention group
Group type: COMPARATOR
Intervention: Comparison of infection and number of days of treatment with TPN
Number of subjects: 70
Study 8695711 — intervention group
Group type: COMPARATOR
Intervention: Comparison of number of manipulations between groups II and III
Number of subjects: 70
Study 1505148 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (100 mg/kg)
Number of subjects: 11
Study 6702463 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (50 g) after aspirin (1000 mg)
Number of subjects: 6
Study 6702463 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (50 g) after quinidine sulfate (200 mg)
Number of subjects: 6
Study 6702463 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (10%)
Number of subjects: 6
Study 6702463 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant ingestion of alcohol (50 g) with drugs
Number of subjects: 6
Study 31096648 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower seed extract (500 mg/day)
Number of subjects: 50
Study 31096648 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric placebo
Number of subjects: 50
Study 29334275 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian drilling (LOD)
Number of subjects: 250
Study 29334275 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist (Cetrotide 0.25 mg) combined with cabergoline (0.5 mg a day for 8 days)
Number of subjects: 250
Study 26583952 — intervention group
Group type: EXPERIMENTAL
Intervention: Confocal laser endomicroscopy (CLE)
Number of subjects: 50
Study 24985574 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% pranoprofen (PRA) plus 0.1% sodium hyaluronate (SH)
Number of subjects: 115
Study 24985574 — intervention group
Group type: COMPARATOR
Intervention: 0.1% sodium hyaluronate (SH) only
Number of subjects: 115
Study 22840583 — intervention group
Group type: EXPERIMENTAL
Intervention: Forest environment (two-night trip to a broad-leaved evergreen forest)
Number of subjects: 20
Study 22840583 — intervention group
Group type: COMPARATOR
Intervention: City area (control group)
Number of subjects: 20
Study 20400723 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable dental prostheses (RDP) for molar replacement
Number of subjects: 215
Study 20400723 — intervention group
Group type: COMPARATOR
Intervention: No replacement (SDA)
Number of subjects: 215
Study 17656221 — intervention group
Group type: EXPERIMENTAL
Intervention: zoledronic acid
Number of subjects: 120
Study 17656221 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120
Study 16302838 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 96
Study 16302838 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier use while held by mothers
Number of subjects: 96
Study 16302838 — intervention group
Group type: COMPARATOR
Intervention: Pacifier use while held by nonmothers
Number of subjects: 96
Study 11973385 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser trephination
Number of subjects: 170
Study 11973385 — intervention group
Group type: COMPARATOR
Intervention: Motor trephination (Control)
Number of subjects: 170
Study 9862245 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b (IFN) 3 million IU thrice weekly s.c. alone
Number of subjects: 0
Study 9862245 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin 600 mg twice daily p.o. alone
Number of subjects: 0
Study 9862245 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of IFN and ribavirin
Number of subjects: 0
Study 9862245 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha‐2b (IFN) alone
Number of subjects: 0
Study 9862245 — intervention group
Group type: COMPARATOR
Intervention: Ribavirin alone
Number of subjects: 0
Study 9862245 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (IFN + ribavirin)
Number of subjects: 0
Study 8536590 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position (Hmax/Mmax = 73.6%)
Number of subjects: 25
Study 8536590 — intervention group
Group type: COMPARATOR
Intervention: Standing position (Hmax/Mmax = 32.4%)
Number of subjects: 25
Study 8536590 — intervention group
Group type: EXPERIMENTAL
Intervention: Old subjects who depressed the reflex (O-D, n = 6)
Number of subjects: 25
Study 8536590 — intervention group
Group type: EXPERIMENTAL
Intervention: Old subjects who did not depress the reflex (O-ND, n = 9)
Number of subjects: 25
Study 2146325 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-cis retinoic acid (1 mg/kg/day for 4 months)
Number of subjects: 26
Study 2146325 — intervention group
Group type: COMPARATOR
Intervention: Control group (no 13-cis RA)
Number of subjects: 26
Study 524332 — intervention group
Group type: EXPERIMENTAL
Intervention: Björk-Shiley (B-S) valve
Number of subjects: 48
Study 524332 — intervention group
Group type: COMPARATOR
Intervention: Lillehei-Kaster (L-K) valve
Number of subjects: 48
Study 31830885 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg
Number of subjects: 25
Study 31830885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31830885 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 25
Study 31509971 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG) for 3 months
Number of subjects: 44
Study 31509971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 31509971 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG)
Number of subjects: 44
Study 29727544 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuyang Huayu Prescription (Traditional Chinese Medicine)
Number of subjects: 54
Study 29727544 — intervention group
Group type: COMPARATOR
Intervention: Endocrine therapy and chemotherapy (Control)
Number of subjects: 54
Study 26282418 — intervention group
Group type: EXPERIMENTAL
Intervention: Ombitasvir plus paritaprevir/ritonavir (with or without ribavirin)
Number of subjects: 132
Study 26282418 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 132
Study 23334341 — intervention group
Group type: EXPERIMENTAL
Intervention: AVAXIM 80U Pediatric
Number of subjects: 720
Study 23334341 — intervention group
Group type: COMPARATOR
Intervention: HAVRIX 720
Number of subjects: 720
Study 20625336 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-only training
Number of subjects: 69
Study 20625336 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated feedback only
Number of subjects: 69
Study 20625336 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor training combined with automated feedback
Number of subjects: 69
Study 19950808 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional technique
Number of subjects: 30
Study 19950808 — intervention group
Group type: COMPARATOR
Intervention: Piggyback technique
Number of subjects: 30
Study 19950808 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 30
Study 16407806 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 0
Study 16407806 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural analgesia
Number of subjects: 0
Study 16407806 — intervention group
Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 0
Study 16407806 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia and combined spinal-epidural analgesia
Number of subjects: 0
Study 15013244 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 206
Study 15013244 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 206
Study 15013244 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 206
Study 15013244 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 206
Study 11686809 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating rotating electric toothbrush with faster head movement
Number of subjects: 24
Study 11686809 — intervention group
Group type: COMPARATOR
Intervention: Oscillating rotating electric toothbrush with slower head movement
Number of subjects: 24
Study 11686809 — intervention group
Group type: COMPARATOR
Intervention: Oscillating rotating reciprocating model
Number of subjects: 24
Study 9598257 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 30
Study 9598257 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 30
Study 7945822 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey-impregnated gauze
Number of subjects: 64
Study 7945822 — intervention group
Group type: COMPARATOR
Intervention: Amniotic membrane
Number of subjects: 64
Study 3556145 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan 250 mg
Number of subjects: 21
Study 3556145 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan 500 mg
Number of subjects: 21
Study 3556145 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan with sodium salicylate
Number of subjects: 21
Study 3556145 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 31618812 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron (20 mg)
Number of subjects: 31
Study 31618812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 28181975 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure therapy (2 weeks, 2 times per week, using auricular acupressure needle on skin paper tape)
Number of subjects: 67
Study 28181975 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (skin paper tape without auricular acupressure needle)
Number of subjects: 67
Study 25956572 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% tacrolimus eye drop
Number of subjects: 24
Study 25956572 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (almond oil)
Number of subjects: 24
Study 23725688 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane 1%-3%
Number of subjects: 32
Study 23725688 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 32
Study 21570617 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60
Study 21570617 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 21570617 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 60
Study 21570617 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 60
Study 19231397 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (standard antiarrhythmic dose)
Number of subjects: 158
Study 19231397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 17163356 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors (ACEIs)
Number of subjects: 60
Study 17163356 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 60
Study 17163356 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 60
Study 15129937 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear implantation with pre-implantation control of OM using a structured protocol and ventilating tube insertion if necessary.
Number of subjects: 60
Study 15129937 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear implantation in OM-prone children with a structured protocol.
Number of subjects: 60